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Summary 
The population Br19 corresponds to the hybrids obtained by the cross of a tetraploid synthetic 
population of sexual genotypes used as female parents and CIAT 606 used as male tester. The 
tetraploid synthetic population of sexual genotypes consisted of the ninth cross of recurrent selection 
of the breeding program.  The methodology to evaluate the hybrid performance starts by germinating 
around 8000 hybrid seeds, out of them 7144 plants were obtained, and samples were taken in order 
to apply marker-assisted selection to separate apomictic and sexual. As this is a trait, which segregates 
mendelian, near half of the population is discarded by the sexual behavior and only 3507 apomictic 
genotypes were established afterwards on the field to measure the hybrid performance for the 
following traits: Visual assessment of biomass production, vigor, high, visual assessment of leaf steam 
ratio and drone based measurements like biomass and greenness. The trials were stablished at two 
locations: CIAT Palmira and Llanos-Cabuyaro. Each trial followed an augmented design with 46 
incomplete blocks. At the end, we expect to complete data for various cuttings in each location, each 
cutting after 6 weeks from previous one, to pursue two cuttings from the dry and two from the wet 
season. Currently, two evaluations have been taken in each location.  
General Objective 
First phenotypic evaluation to identify apomictic hybrids of the population Br19 that 
outperform the commercial benchmark in at least one of the traits of environmental and economic 
importance, without reducing the performance in any other important trait.  
Methodology and results 
1. Germination and plantlet development in the glasshouse: The process started in November 
from 2018 with the selection and scarification of the seeds to be planted in January 2019 (as 
shown in Table 1).  
 
 
 Table 1: List of activities from hybrid seed selection to establishment of field trials.  
 
 
 
Figure1: Seed germination for each family of sexual female parent Sx18.  
 
2. Sample for DNA extraction, and marker assisted selection for the trait apomixes with the 
primers p779/p780 occurred during February until March 2019. At the end, the population size 
of plant to be established in the field was 2500.  
Table 2: Description of population sizes subjected to each step: Total of seeds germinated, proportion 
of apomictic/sexual and final population size of apomictic hybrids for the field.   
 
3. Establishment of trials in two locations. Field trials followed the augmented design with 46 
incomplete blocks in two locations, Llanos and Palmira. In Llanos two replicates were planted, 
each following a different soil treatment, to simulate different “environments”. The following 
figure show the map of both trials.  
 
Figure 2: Map of the field trial in Llanos. 
 
 Figure 3: Map of the field trial in Palmira.  
4. Standardization cuttings and evaluations: Currently we have evaluated twice in each locations. 
Still two evaluations in each trial is needed to complete the dataset.  
   
Next steps:  
1. Complete two more evaluations in each location 
2. Statistical analysis and selection: We will analyze the data using R in the friendly environment 
of RStudio; using packages as AsReml and Agricolae. We aim to calculate, variance 
components, best unbiased predictors of the means for each genotype in each location and 
analyses genotype by environment interaction using genetic correlations as well as AMMI 
analyses. Finally, a selection index will be used to identify the hybrids to be advance to the 
next selections phase.  
3. Quality measurements for pre-selection at least in one location and one cutting using NIRS 
equations. 
4. Final selection of hybrids that will be promoted to the phase of testing 2: Multi-
environmental trial.  
 
  
